Abstract
We hereby report a 1-year follow-up on eight women in the first North America trial in which stress urinary incontinence (SUI) was treated with muscle-derived stem cell injections. Mean and median follow-up in this group was 16.5 and 17 months (range 3–24 months). Improvement in SUI was seen in five of eight women, with one achieving total continence. Onset of improvement was between 3 and 8 months after injection. Cure or improvement continued at a median of 10 months. No serious adverse events were reported.
References
Norton P, Brubaker L (2006) Urinary incontinence in women. Lancet 367:57–67
Kiilholma P, Chancellor MB, Makinen J, Hirsch IH, Klemi PJ (1993) Complications of Teflon injections for stress urinary incontinence. Neurourol Urodyn 12:131–137
Huard J, Yokoyama T, Pruchnic R, Qu Z, Li Y, Lee JY, Somogyi GT, de Groat WT, Chancellor MB (2002) Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 9:1617–1626
Rodriguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ (2006) Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. PNAS 103:12167–12172
Strasser H, Marksteiner R, Margreiter E (2006) Transurethral ultrasound guided stem cell therapy of urinary incontinence. J Urol 175:291–292
Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tubita K, Keller BB, Cummins JH, Huard J (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12:1130–1141
Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates G, Robbins P, Wernig A, Huard J (2000) Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150:1085–1100
Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851–864
Kwon D, Kim Y, Pruchnic R, Jankowski R, Isiene I, de Miguel F, Huard J, Chancellor MB (2006) Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 68:449–454
Conflicts of interest
L.K. Carr, D. Steele, S. Steele and J. Erickson have received research grant support from Cook.
J Huard, M.B. Chancellor are consultant to Cook and have received research grants from Cook.
D. Wagner, R. Pruchnic and R. Jankowski are employees of Cook.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding: Cook MyoSite, Inc.
Rights and permissions
About this article
Cite this article
Carr, L.K., Steele, D., Steele, S. et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J 19, 881–883 (2008). https://doi.org/10.1007/s00192-007-0553-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-007-0553-z